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Abstract 
Although cigarette smokers with co-occurring pain report experiencing more severe nicotine 
withdrawal and greater difficulty quitting, limited work has examined the role of pain in smoking 
cessation-related outcomes. The goal of this study was to examine clinically-relevant pain 
characteristics (i.e., pain persistence, pain intensity, and pain-related disability) as predictors of 
withdrawal and smoking lapse/relapse outcomes using an established laboratory model of 
cessation. Participants (N = 120 daily cigarette smokers; 48% male; MAge = 36.17, SD = 12.16; 
MCPD = 20.51, SD = 6.99) were randomized to either continued smoking or 12-hour nicotine 
deprivation conditions prior to an experimental study visit. Upon arrival to the laboratory, 
participants completed measures of pain characteristics and nicotine withdrawal symptoms. 
Primary outcomes included nicotine withdrawal scores and analogs of smoking lapse (i.e., 
latency to initiating smoking) and relapse (i.e., number of cigarettes smoked). Results indicated 
that persistent pain and nicotine deprivation each predicted more severe nicotine withdrawal. 
Cox regression analyses further revealed that moderate-to-severe pain-related disability and 
nicotine deprivation each predicted quicker latency to lapse during the laboratory cessation 
paradigm. Contrary to expectation, there were no statistically-significant interactions between 
nicotine deprivation and pain characteristics. Clinical implications include the possibility that 
smokers with pain would likely benefit from tailored and integrated cessation treatment.  
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Pain Characteristics and Nicotine Deprivation as  
Predictors of Performance during a Laboratory Model of Smoking Cessation 
Pain and cigarette smoking are highly prevalent and co-occurring, with a combined 
annual economic burden of more than $800 billion in the United States alone (Gaskin & Richard, 
2012; USDHHS, 2014; Xu, Bishop, Kennedy, Simpson, & Pechacek, 2015). Accordingly, there 
has been increasing empirical focus on the role of pain in the onset and maintenance of tobacco 
addiction. Initial research suggests that smokers with pain may be less likely to successfully quit 
smoking. However, limited research has directly examined the role of pain in smoking cessation 
outcomes. The current study is the first to test whether several clinically-relevant pain 
characteristics (i.e., pain persistence, pain intensity, and pain-related disability) predicted 
nicotine withdrawal and lapse/relapse outcomes assessed using a laboratory paradigm of 
smoking cessation. We also tested whether nicotine deprivation moderated effects of pain 
characteristics on smoking withdrawal, lapse, and relapse outcomes.  
Overview of Pain and Smoking 
Pain 
Pain is a subjective experience that is inherently unpleasant, interrupts attention and 
behavior, and compels one to escape its presence (Eccleston & Crombez, 1999; Price, 2000). 
Approximately half of all U.S. adults endorse past three-month pain, and more than 25 million 
suffer from pain that occurs every day (Nahin, 2015). Greater severity of pain has been 
associated with a variety of negative health effects, including major depressive disorder, 
insomnia, and greater impairment and disability (Finan & Smith, 2013; Goesling, Clauw, & 
Hassett, 2013; Lee et al., 2015). Pain also represents an enormous public health burden, 
motivating up to half of all annual physician visits in the United States, and accounting for an 
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annual economic impact of up to $635 billion in healthcare costs and lost productivity (Gaskin & 
Richard, 2012; IOM, 2011; Mayo Clinic, 2001; McCarberg, 2011).  
Traditional assessments of pain severity focus on duration, such that longer-lasting pain 
is considered to be more severe (Merskey & Bogduk, 1994). Although duration of pain remains 
an important factor (e.g., Treede et al., 2015), there is growing recognition that pain is 
multidimensional, and that approaches to characterizing pain should incorporate indices of 
persistence, intensity, and disability (Turk & Melzack, 2011).  
Persistence. Pain persistence is typically assessed via frequency of symptoms over a 
specific time period (e.g., number of days having experienced pain over the previous six months; 
Force, 2010; Merskey & Bogduk, 1994). For example, individuals who report pain on ≥ 90 out 
of the last 180 days are considered to have a persistent pain condition (Von Korff, Ormel, Keefe, 
& Dworkin, 1992). Prevalence estimates indicate that up to 19% of adults in the United States 
general population meet criteria for persistent pain (Kennedy, Roll, Schraudner, Murphy, & 
McPherson, 2014). Persistent pain has been shown to negatively impact a variety of health-
relevant outcomes, including sleep, brain function, cardiovascular activity, and sexual function 
(Chapman & Gavrin, 1999). Among a nationally representative sample, individuals who met 
criteria for persistent pain (vs. non-persistent pain) endorsed higher rates of depression, anxiety, 
and fatigue (Kennedy et al., 2014). Pain persistence has also been uniquely associated with 
increased odds of substance use after detoxification among adults with substance use disorders 
(Larson et al., 2007). 
Intensity. Valid measures of pain intensity include numerical rating scales, visual 
analogue scales, and verbal rating scales (Thong, Jensen, Miró, & Tan, 2018). Numerical rating 
scales tend to be the most commonly utilized (i.e., 0-10, 0-100; Turk & Melzack, 2011) and are 
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among the least influenced by non-pain intensity factors (e.g. depressive symptoms, 
catastrophizing; Thong et al., 2018). Researchers have further suggested that composite measures 
of average pain, pain at its worst, and current pain yield more comprehensive clinical data that 
can be used to better index characteristic pain intensity (Von Korff et al., 1992). In comparison 
to pain persistence, pain intensity has been shown to be a stronger predictor of healthcare costs 
and utilization of medical care among clinical pain patients (Pérez, Navarro, Saldaña, Wilson, & 
Rejas, 2015). Moderate-to-severe pain intensity has also been associated with lower rates of 
abstinence, greater substance use, and greater service utilization among individuals in outpatient 
addiction treatment (Caldeiro et al., 2008). Greater pain intensity has further been shown to 
predict a higher likelihood of meeting criteria for a substance-related disorder (Higgins et al., 
2014).  
Disability. Pain-related disability encompasses a variety of domains, including the 
impact of pain on physical, occupational, recreational, and social functioning. Self-report 
measures of pain-related disability typically assess degree of interference with work, school, 
housework, recreational, and social or family activities (Von Korff et al., 1992). Frequency with 
which pain interferes with functioning is also often assessed. Similar to pain intensity, a 
composite score can be generated to index pain-related disability. In comparison to either 
persistence or intensity, pain-related disability has been more strongly associated with likelihood 
of unemployment, severe anxious/depressive symptoms, and greater utilization of healthcare 
resources (Bean, Johnson, & Kydd, 2014; Häuser et al., 2014; Ma, Chan, & Carruthers, 2014). 
There is also growing empirical support for the notion that pain-related disability may play a 
unique role in the maintenance of substance use (Zale & Ditre, 2015; Zale, Lange, Fields, & 
Ditre, 2013). For example, greater pain-related disability has been associated with the presence 
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of alcohol, nicotine, and cannabis use disorders (McDermott, Joyner, Hakes, Okey, & Cougle, 
2018).  
Measures of pain persistence, pain intensity, and pain-related disability tend to be 
moderately correlated (Schmidt, Raspe, & Kohlmann, 2010; Von Korff et al., 1992). For 
example, a recent systematic review found that individuals who endorsed greater pain intensity 
also reported greater disability, poorer functioning, and greater frequency of pain symptoms 
(Kooijman et al., 2015). Although measures of pain intensity and pain-related disability are often 
the most highly correlated (Turk & Melzack, 2011), measures of pain persistence tend to be only 
slightly-to-moderately correlated with pain intensity and pain-related disability (Von Korff et al., 
1992). In summary, persistence, intensity, and disability each represent distinct and clinically-
relevant characteristics of the pain experience.   
Cigarette Smoking  
More than fifty years after the first Surgeon General’s report warning on the health 
hazards of smoking cigarettes (USDHHS, 1964), tobacco use remains the leading preventable 
cause of mortality worldwide (WHO, 2017), accounting for an annual economic burden of more 
than $300 billion in the United States alone (USDHHS, 2014). Almost 70% of all smokers report 
a desire to quit, but only 5% successfully achieve abstinence (CDC, 2011), and most relapse 
within one week of initiating a quit attempt (Partos, Borland, Yong, Hyland, & Cummings, 
2013). Thus, despite substantial empirical progress in the identification of reliable predictors of 
smoking cessation (e.g., nicotine dependence, withdrawal symptoms, self-efficacy for quitting; 
Brandon, Drobes, Ditre, & Elibero, 2009), there is a clear need to better understand additional 
factors that may play a role in the continuation of smoking.  
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Nicotine withdrawal. Nicotine withdrawal (Koob & Le Moal, 2001; Piper et al., 2011) 
comprises subjective, cognitive, and physiological symptoms that can emerge within 30 minutes 
of abstinence (Hendricks, Ditre, Drobes, & Brandon, 2006) and typically last up to four weeks 
(Leventhal, Waters, Moolchan, Heishman, & Pickworth, 2010; McLaughlin, Dani, & De Biasi, 
2015). Withdrawal severity consistently predicts cessation failure (McCarthy, Piasecki, Fiore, & 
Baker, 2006; Piasecki et al., 2000), and assessing nicotine withdrawal symptoms at the beginning 
of a quit attempt may facilitate detection of those most at-risk for relapse. Because withdrawal 
begins almost immediately after finishing a cigarette (Hendricks et al., 2006), there is also 
increasing focus on assessing incipient withdrawal symptoms among current smokers. Electronic 
diary studies suggest that daily patterns of withdrawal may be a mechanism that drives continued 
smoking (Chandra, Scharf, & Shiffman, 2011; Perkins, Briski, Fonte, Scott, & Lerman, 2009). In 
fact, greater reported withdrawal severity among current smokers has been shown to predict 
lower likelihood of reducing smoking and initiating a quit attempt in the future (Weinberger, 
Desai, & McKee, 2010; Weinberger, Platt, Shuter, & Goodwin, 2016). Therefore, assessment of 
withdrawal both among current smokers and recent quitters provides a useful metric in 
predicting the likelihood of current or future cessation success. 
Translational paradigms of smoking cessation. Large-scale clinical trials that identify 
predictors of smoking lapse (i.e., time between initial abstinence and smoking again) and relapse 
(i.e., transition from lapse to continued smoking) require substantial time, effort, and expense. 
Laboratory paradigms of smoking cessation are useful and efficient methods of examining 
precipitants of cessation milestones in a controlled, experimental setting. McKee and colleagues 
developed a laboratory paradigm of smoking cessation that is widely used to assess lapse and 
relapse behavior during a single session by providing financial incentives for abstinence from 
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cigarettes (McKee, 2009; McKee, Weinberger, Shi, Tetrault, & Coppola, 2012). In this 
paradigm, lapse behavior is assessed via the number of minutes participants maintain smoking 
abstinence during a 50-minute period, and relapse behavior is assessed via the number of 
cigarettes smoked during a 60-minute period following the initial lapse.  
Studies using this laboratory paradigm have verified antecedents to lapse and relapse 
commonly observed in treatment outcome research, such as acute nicotine deprivation (Leeman, 
O’Malley, White, & McKee, 2010; Leventhal et al., 2014), cigarette craving (Roche et al., 2014), 
anhedonia (Leventhal et al., 2014), negative affect/stress (Leventhal et al., 2014; McKee et al., 
2011), alcohol consumption (McKee, Krishnan-Sarin, Shi, Mase, & O’Malley, 2006), and gender 
(Pang & Leventhal, 2013). Furthermore, this paradigm has been used to identify and screen 
potential cessation pharmacotherapies (Verplaetse et al., 2017) and behavioral interventions 
(Moody, Poe, & Bickel, 2017). 
Prevalence of Pain and Smoking 
There has been increasing empirical interest in pain and tobacco cigarette smoking, as 
both are highly prevalent and co-occurring conditions (Ditre, Brandon, Zale, & Meagher, 2011; 
Martel, Shir, & Ware, 2017; Parkerson, Zvolensky, & Asmundson, 2013). Rates of smoking 
among persons with pain are two to three times that observed in the general population, with 
even higher rates among treatment-seeking pain patients (Michna et al., 2004; Zvolensky, 
McMillan, Gonzalez, & Asmundson, 2009). Accumulating research further suggests that 
cigarette smokers experience greater prevalence and intensity of pain than nonsmokers. For 
example, when compared to individuals who have never smoked cigarettes, both current and 
former smokers evince a greater risk of lifetime pain (e.g., Palmer, Syddall, Cooper, & Coggon, 
2003). In addition, a recent study among daily smokers found that approximately 40% met 
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criteria for chronic pain (Bakhshaie et al., 2016), compared to approximately 30% in the general 
population (Johannes, Le, Zhou, Johnston, & Dworkin, 2010).  
Interrelations Between Pain and Tobacco Smoking  
An evolving reciprocal model posits that tobacco use and pain interact in the manner of a 
positive feedback loop, resulting in greater pain and maintenance of tobacco dependence (Ditre 
et al., 2011; Ditre, Zale, & LaRowe, 2019; Zale, Maisto, & Ditre, 2016). The reciprocal model 
can be broken down into the effects of smoking on pain (e.g., tobacco smoking as a risk factor in 
the onset of painful conditions), and the effects of pain on smoking (e.g., pain as a proximal 
antecedent of smoking behavior). Consistent with the first line of empirical inquiry, cigarette 
smoking has been identified as a unique risk factor in the onset and progression of several 
painful conditions (e.g., Aho & Heliovaara, 2004; Shiri, Karppinen, Leino-Arjas, Solovieva, & 
Viikari-Juntura, 2010). A recent meta-analysis further showed that nicotine produces acute 
analgesic effects (Ditre, Heckman, Zale, Kosiba, & Maisto, 2016), and chronic pain patients 
have reliably endorsed the use of cigarettes to cope with pain (e.g., Jamison, Stetson, & Parris, 
1991; Patterson et al., 2012). Emerging research further suggests that nicotine deprivation is 
associated with greater self-reported pain intensity (LaRowe, Kosiba, Zale, & Ditre, 2018) and 
increased sensitivity to experimental pain induction (Ditre, Zale, LaRowe, Kosiba, & De Vita, 
2018; Nakajima & Al'Absi, 2014).  
When examining the second direction of the reciprocal model (i.e., the effects of pain on 
smoking), converging research indicates that pain can be a potent motivator of tobacco smoking 
(Dhingra et al., 2014; Ditre & Brandon, 2008; Ditre, Heckman, Butts, & Brandon, 2010; Kosiba, 
Zale, & Ditre, 2018). Smokers undergoing experimental pain induction (vs. no pain induction) 
have reported greater urge for cigarettes (Ditre & Brandon, 2008), and exposure to painful 
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stimuli has been associated with increased tobacco craving and withdrawal symptoms (Kotlyar et 
al., 2011; Parkerson & Asmundson, 2016). Ecological momentary assessment research has 
further shown that painful episodes often precede bouts of smoking (Dhingra et al., 2014). 
Finally, cross-sectional studies provide evidence that more intense daily pain is associated with 
greater number of cigarettes smoked per day (Aigner et al., 2015), and that smokers in pain (vs. 
without pain) tend to endorse more central features of tobacco dependence (e.g., craving, 
tolerance, automaticity, loss of control; Ditre, Kosiba, Zale, Zvolensky, & Maisto, 2016). 
Pain and smoking cessation. Given established effects of pain on smoking behavior, an 
important next step is to examine the role of pain in the context of quitting. Although 
preliminary, the extant literature suggests that pain may influence various cessation-related 
outcomes, including pre-cessation processes (e.g., self-efficacy, expectancies for quitting), the 
subjective quality of quit attempts (e.g., perceived difficulty, withdrawal), and lapse/relapse to 
smoking. For example, smokers with pain have reported lower confidence in their ability to stay 
quit (Zale, Ditre, Dorfman, Heckman, & Brandon, 2014), and a greater number of unsuccessful 
past attempts to quit smoking (Waldie, McGee, Reeder, & Poulton, 2008). Chronic pain status 
has been associated with expectations for experiencing more severe withdrawal during future 
cessation attempts (Ditre et al., 2016), and smokers with co-occurring pain (vs. no pain) are 
nearly 3.5 times more likely to identify pain as a barrier to cessation (Ditre, Zale, Heckman, & 
Hendricks, 2017).   
Despite emerging evidence that pain may influence smoking cessation, no research has 
directly examined pain as a predictor of nicotine withdrawal, and only three studies have 
examined associations between pain- and smoking abstinence-related outcomes. First, in a single 
experimental study, individuals who smoked at least 10 cigarettes per day (N = 71) completed a 
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baseline assessment of pain perception using a cold pressor test (CPT) prior to initiating a quit 
attempt (Nakajima & al'Absi, 2011). Within the first four weeks of cessation, individuals with 
greater pre-quit sensitivity to CPT at baseline were more likely to relapse to smoking. A second 
study examined pain-related anxiety (i.e., the tendency to respond to pain with anxiety or fear) as 
a predictor of lapse (i.e., the first act of smoking after a quit attempt) and relapse (i.e., return to 
regular smoking) among 55 daily cigarette smokers who attempted to quit without pychosocial 
or pharmacological cessation aids (LaRowe, Langdon, Zvolensky, Zale, & Ditre, 2017). Results 
indicated that higher pain-related anxiety predicted both greater likelihood and faster trajectory 
to lapse and relapse during the 90-day follow-up period. Finally, a sample of daily smokers with 
human immunodeficiency virus (HIV; N = 474; MCPD = 19.15) completed either usual care or 
usual care plus 11 sessions of cell phone-delivered smoking cessation treatment (Aigner et al., 
2017). Usual care included meeting briefly with a clinician, self-help written materials, and 
information about nicotine replacement therapy. During the 12-month follow-up period, 
participants with more intense pain were found to be less likely to achieve 24-hour point 
prevalence smoking abstinence, regardless of treatment condition assignment.  
These initial findings suggest that pain and related constructs are associated with poorer 
cessation outcomes. However, these studies are limited in that they examine only narrow 
constructs of pain (i.e., pain-related anxiety, sensitivity to laboratory pain induction) or specific 
populations (i.e., smokers with HIV). Further examining established pain characteristics (i.e., 
pain persistence, pain intensity, and pain-related disability) in relation to smoking cessation 
outcomes may help address this gap in the literature, as they are often assessed in both clinical 
research and practice, and have been shown to differentially predict substance use and health 
outcomes. For example, greater average pain intensity among smokers has been negatively 
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associated with likelihood of initiating a quit attempt, and positively associated with greater 
number of cigarettes smoked per day (Aigner et al., 2015). Pain patients who smoke also report 
more intense pain and pain-related disability, compared to their nonsmoking counterparts 
(Hooten, Shi, Gazelka, & Warner, 2011; Weingarten et al., 2008).  
Pain Characteristics and Theoretical Frameworks of Addiction 
The current study will be the first to assess whether several clinically-important pain 
characteristics (i.e., persistent pain, pain intensity, and pain-related disability) predict smoking 
cessation-relevant outcomes. Allostatic load and negative reinforcement theoretical perspectives 
are commonly applied to the study of both pain and substance use, and directly informed the 
current study. 
Allostatic Load Models  
Allostasis refers to the process by which physiological systems maintain stability in the 
face of change (McEwen & Wingfield, 2003). Through opponent-processes, continued cycles of 
substance use result in physiological imbalances that can dysregulate reward processing and 
drive further substance use (Elman & Borsook, 2016). The accumulation of these maladaptive 
imbalances is referred to as allostatic load. Although allostatic load conceptualizations are 
commonly used to explain substance use, research has also implicated pain as another stressor 
that contributes to allostatic load (Simons, Elman, & Borsook, 2014). In this context, repeated 
bouts of pain and substance use can dysregulate overlapping neural systems responsible for both 
pain and reward processing, which in turn may engender a pathological state that favors more 
intense pain and drug-seeking behavior. Thus, greater persistence of pain and continued smoking 
may both serve as risk factors that contribute to the maintenance of tobacco addiction and the 
worsening of pain.  
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Negative Reinforcement Models  
Associations between tobacco smoking and pain intensity/disability may be explained, in 
part, by negative reinforcement conceptualizations of addiction. Negative reinforcement 
frameworks posit that substance use is largely motivated by the desire to alleviate or avoid 
aversive internal states, and it has been hypothesized that using substances to cope with negative 
affect plays a central role in the development of substance use disorders (Baker, Piper, 
McCarthy, Majeskie, & Fiore, 2004). Given the acute analgesic properties of nicotine (Ditre et 
al., 2016), smokers experiencing increased negative affect due to pain intensity/interference may 
be more prone to using cigarettes for acute self-medication. However, regular cigarette smoking 
is also associated with the onset and progression of several chronically painful conditions, which 
in turn may motivate continued use of nicotine (Ditre et al., 2011). For example, chronic pain 
patients who reported using smoking as a pain-coping strategy were found to score significantly 
worse on measures of pain intensity, pain-related disability, and fear of pain, relative to 
nonsmokers or smokers who denied using cigarettes to cope with pain (Patterson et al., 2012). 
Although no previous work has examined pain intensity and pain-related disability in relation to 
smoking cessation-relevant outcomes, negative reinforcement models suggest that these 
characteristics may play an important role in the experience of withdrawal and relapse to 
smoking.   
The Current Study  
The goal of current was to test whether several clinically-relevant pain characteristics 
(i.e., persistent pain, pain intensity, and pain-related disability) predict severity of self-reported 
nicotine withdrawal and performance during a laboratory paradigm of smoking cessation. These 
data were collected as part of a primary study examining the role of self-control depletion and 
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nicotine deprivation on lapse and relapse outcomes (Heckman et al., 2017). In the nicotine 
deprivation manipulation, participants were randomized to either deprived (12 hours of nicotine 
deprivation) or non-deprived groups prior to completing all experimental activities. Thus, we 
also tested an interaction between nicotine deprivation condition assignment and pain 
characteristics to determine if nicotine deprivation confers a moderating effect on nicotine 
withdrawal and lapse/relapse outcomes.  
We hypothesized that participants with persistent pain, high pain intensity, or moderate-
to-severe pain-related disability would score higher on a measure of nicotine withdrawal and 
evince poorer performance during a laboratory paradigm of cessation (i.e., quicker latency to 
smoking, and smoking a greater number of cigarettes after initiating smoking). In a secondary 
aim, we also examined whether nicotine deprivation moderated these outcomes. Specifically, we 
hypothesized that participants with persistent pain, high pain intensity, or moderate-to-severe 
pain-related disability, who were also deprived of cigarettes for 12 hours prior to the baseline 
session, would score higher on a measure of nicotine withdrawal symptoms, would demonstrate 
the fastest latency to first cigarette (i.e., lapse), and would smoke a greater number of cigarettes 
(i.e., relapse) during the laboratory paradigm, relative to non-deprived participants.  
Method 
Participants 
Adult smokers were recruited from the Tampa, FL, area via print and internet 
advertisements for an experimental study examining nicotine deprivation and self-control 
processes (Heckman et al., 2017). Prospective participants completed a telephone screener to 
determine eligibility. Inclusion criteria comprised: English-speaking; age 18-65; smoke at least 
15 cigarettes per day for at least 1 year; able to provide a valid, stable mailing address and phone 
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number. Exclusion criteria included: concurrent use of other nicotine or tobacco products; 
actively attempting to quit smoking; currently pregnant; hearing or visual impairment that would 
interfere with study procedures. A total of 120 participants attended the baseline assessment and 
completed the laboratory paradigm of smoking cessation (Figure 1).    
Measures  
Smoking and sociodemographic characteristics. Participants completed a smoking 
history form that assessed daily cigarette consumption and smoking duration. The smoking 
history form also included an index of cessation self-efficacy that aggregated confidence in the 
ability to quit smoking for a week, month, and year (α = .79), and the Fagerström Test for 
Nicotine Dependence (FTND; Heatherton, Kozlowski, Frecker, & Fagerstrom, 1991), which is a 
widely used and valid measure of nicotine dependence. Finally, participants self-reported 
information about sociodemographic characteristics (e.g., gender, race, education).   
 Nicotine deprivation manipulation check. Compliance with the deprivation 
manipulation was verified via self-reported time since last cigarette and pre-session expired 
carbon monoxide (CO) concentration levels. Participants randomized to the deprivation 
condition (vs. non-deprived condition) were required to have a CO of ≤ 11ppm (Leventhal et al., 
2010). Non-deprived participants were required to have a CO level greater than 11ppm.  
Nicotine withdrawal. The Minnesota Nicotine Withdrawal Scale (MNWS; Hughes & 
Hatsukami, 1986) was used to assess the severity of nine prototypical nicotine withdrawal 
symptoms over the past 12 hours (e.g., desire or craving to smoke) on a scale from 0 (none) to 4 
(severe). Individual items were averaged to generate a total withdrawal severity score (α = .82). 
Pain Characteristics. The Graded Chronic Pain Scale (GCPS; Von Korff, Ormel, Keefe, 
& Dworkin, 1992) was used to assess pain persistence, pain intensity, and pain-related disability. 
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The GCPS has frequently been used to assess pain among both clinical and nonclinical samples 
(Turk & Melzack, 2011). The persistence classification score was based on a single item. 
Specifically, participants reported the number of days they had experienced pain in the past 180 
days, and responses ranging from 90-180 days were classified as persistent pain (≤ 89 days = no 
persistent pain) per scoring recommendations (Von Korff et al., 1992). The characteristic pain 
intensity score included summed responses to three questions where participants rated their pain 
“right now,” “on average,” and the “worst” pain they had experienced in the past three months 
on an 11-point scale (0 = no pain to 10 = pain as bad as it could be). Total scores ranged from 0-
30. Participants were then grouped according to their characteristic pain intensity (none-to-low 
intensity vs. high intensity; Adams et al., 2018; Urquhart, Shortreed, Davis, Cicuttini, & Bell, 
2009). The disability score was based on the sum of responses from three items assessing 
interference of pain with daily functioning over the past 3 months on an 11-point scale (0 = no 
interference to 10 = unable to carry on any activities) and one item measuring the number of 
days pain interfered with usual activities on an 11-point scale (0 = none to 10 = 76-90 days). 
Total disability scores ranged from 0-40. Consistent with previous work (Ozdemir-Karatas, 
Peker, Balık, Uysal, & Tuncer, 2013), pain-related disability status was dichotomized (moderate-
to-severe vs. none-to-low).  
Lapse and relapse behavior. The smoking cessation laboratory paradigm was developed 
by McKee and colleagues (McKee, 2009; McKee et al., 2012) to assess lapse and relapse 
behavior in a single experimental session. See Figure 3 for a timeline of the paradigm. 
Participants are first provided a tray containing eight preferred brand cigarettes, an ashtray, and a 
lighter with instructions that they can begin smoking at any point over the next 50 minutes. They 
are also informed that they could earn $1 for every 5 minutes they delayed smoking, with a 
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maximum payment of $10 over the 50-minute period. Lapse behavior is assessed via time to 
initiating smoking during the 50-minute delay period. After the participant lighted their first 
cigarette or at the ending of the 50-minute period, a 60-minute self-administration smoking 
period began where participants were instructed to “smoke as little or as much as you wish.” In 
this paradigm, relapse behavior is assessed through the number of cigarettes smoked during the 
ad libitum smoking period. Primary outcomes included (a) time to first cigarette in minutes (i.e., 
lapse behavior) and (b) number of cigarettes smoked (i.e., relapse behavior) during the ad libitum 
smoking period.   
Procedure  
Following telephone screening, eligible participants were scheduled for a laboratory 
experimental session and randomized to either a continued smoking condition or a 12-hour 
nicotine deprivation condition. Participants randomized to the continued smoking condition were 
instructed to smoke normally prior to their appointment and to smoke their last cigarette five 
minutes before arriving for their session. Participants randomized to the deprivation condition 
were instructed not to smoke or use any other nicotine products for 12 hours prior to their 
appointment. Upon arrival to the laboratory experimental session, participants provided informed 
consent, and compliance with smoking instructions was verified via self-report and exhaled CO 
(continued smoking > 11ppm; deprivation ≤ 11ppm; Leventhal et al., 2010). Twenty-eight 
participants randomized to the deprivation condition and four participants assigned to the non-
deprived conditions were excluded due to failure to meet pre-session expired CO concentration 
levels (see Figure 1). Participants who were compliant with the smoking instructions then 
completed baseline measures. 
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Participants were then randomized to either a self-control depletion manipulation or no 
self-control depletion (Heckman et al., 2017). The self-control depletion manipulation involved 
watching a six minute emotionally-evocative video clip depicting mutations and death of sea life, 
and instructions to “Remain completely neutral on the inside and out. Please try your best not to 
let any feelings or responses you may have show on your face, and to the best of your ability, try 
to keep all of your internal reactions suppressed” (Baumeister, Bratslavsky, Muraven, & Tice, 
1998; Heckman, Ditre, & Brandon, 2012). Participants in the no self-control depletion condition 
were instructed to “Be as natural as possible, both on the inside and out. If you have any feelings 
or reactions to the movie, let them flow naturally.” All participants were informed that they 
would be video-recorded while watching the clip. The primary study found no significant 
interaction between deprivation and self-control depletion on performance during the laboratory 
paradigm of smoking cessation. However, participants in the self-control depletion condition 
demonstrated a quicker latency to smoking their first cigarette (relative to controls). There was 
also no main effect of depletion on the relapse outcome (i.e., number of cigarettes smoked; ps > 
.05).   
Data Analytic Plan  
 All analyses were conducted using SPSS Statistics 21 (IBM Corp, 2013). First, we ran a 
series of bivariate correlations to test zero-order associations between sociodemographic factors, 
FTND scores (nicotine dependence), MNWS scores (nicotine withdrawal), nicotine deprivation 
condition, pain characteristics (persistent pain, pain intensity, and pain-related disability), time to 
first cigarette (lapse), and number of cigarettes smoked (relapse). Variables that were associated 
with dependent variables (MNWS total score, minutes to lapse, and cigarettes smoked) were 
retained as covariates. Nicotine dependence (FTND scores) and cessation self-efficacy were also 
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included as covariates, given that the primary study found these variables differed as a function 
of deprivation condition (Heckman et al., 2017), and because they have previously been 
associated with nicotine withdrawal and cessation outcomes (e.g. Roche et al., 2014; Schnoll et 
al., 2011; Vangeli, Stapleton, Smit, Borland, & West, 2011). Self-control depletion condition 
was also included as a covariate in all models examining lapse and relapse, as the manipulation 
was completed immediately before the laboratory paradigm and predicted greater lapse behavior.  
Given that moderate-to-high correlations between predictor variables could indicate 
issues with multicollinearity, the variance inflation factor (VIF) for each predictor was also 
assessed. Multicollinearity occurs when two or more predictor variables are highly inter-
correlated, which can result in reduced statistical power. The VIF is commonly used to provide 
an index of the amount of variance that increases due to multicollinearity in an estimated 
regression coefficient, and a VIF of 10 or greater indicates issues with multicollinearity (Myers, 
1990). After assessing the VIF for each of the pain characteristics, there was no indication of 
multicollinearity for pain persistence (VIF = 1.42), pain intensity (VIF = 1.90), or pain-related 
disability (VIF = 1.56). These findings are consistent with existing evidence that pain 
persistence, pain intensity, and pain-related disability represent related, but unique dimensions of 
the pain experience (Schmidt, Raspe, & Kohlmann, 2010; Von Korff et al., 1992).   
Participants were then grouped using GCPS cut-offs for persistent pain (yes/no), high 
pain intensity (yes/no), and moderate-to-severe pain-related disability (yes/no). Descriptive 
statistics were computed to characterize the three groupings with regard to demographic and 
smoking characteristics. 
Distributions of all outcome variables were then examined for normality. Skewness and 
kurtosis fell within acceptable ranges for MNWS scores (nicotine withdrawal) and number of 
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cigarettes smoked (relapse behavior; George & Mallery, 2003). However, examination of the 
distribution of the latency to smoke (lapse behavior) variable revealed both floor and ceiling 
effects, where 11% of participants initiated smoking immediately (n = 14) and almost 46% of 
participants abstained from smoking for the full 50-minute delay period (n = 55). Non-normality 
of the latency to smoke variable has been observed in previous research utilizing the laboratory 
paradigm (Reitzel & Leventhal, 2014; Roche et al., 2014). Therefore, we employed a 
nonparametric approach to analyzing the lapse outcome (i.e., survival analysis).  
First, we examined differences in withdrawal severity (MNWS scores) as a function of 
persistent pain, pain intensity, and pain-related disability using three separate analysis of 
covariance (ANCOVA) models. In each model, we included a deprivation condition x pain 
characteristic interaction term. Significant interactions were probed using the PROCESS Macros 
for SPSS (Preacher & Hayes, 2008).  
Second, we used the Cox proportional hazards model to estimate risk of lapse behavior as 
a function of persistent pain, pain intensity, and pain-related disability. The Cox model is 
frequently used to examine predictors of lapse to cigarette smoking (e.g., Lemieux, Nakajima, 
Hatsukami, Allen, & al’Absi, 2015; Messer et al., 2015; Nakajima & al'Absi, 2011; Schepis, 
Tapscott, & Krishnan-Sarin, 2016; Zvolensky et al., 2008) and this model has also been used to 
identify predictors of lapse outcomes during the laboratory paradigm of smoking cessation 
(Roche et al., 2014). This semiparametric model estimates hazard ratios by examining the pattern 
of covariation of predictor variables with the event of interest (e.g., lapse; Christensen, 1987; 
Cox & Oakes, 1984). Unlike ordinary regression models, the Cox proportional hazards model 
incorporates both ‘censored’ observations (cases are ‘censored’ if the exact survival time is 
unknown; Christensen, 1987) and uncensored observations when estimating model parameters. 
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Consistent with previous research, individuals who did not smoke during the 50-minute delay 
period were censored (Roche et al., 2014). Established procedures for the Cox proportional 
hazards model indicate that a minimum of 5 events should be included per predictor variable to 
increase confidence interval coverage, and decrease relative bias and type I error (Vittinghoff & 
McCulloch, 2007). After ensuring that our models were consistent with this recommendation, 
covariates were entered into the first step. Three separate models were then conducted with pain 
characteristics (i.e., persistent pain, pain intensity, and pain-related disability) and nicotine 
deprivation condition entered at the second step, and a pain characteristic x nicotine deprivation 
interaction term entered at the third step.  
Kaplan Meier survival curves were then used to compare trajectories to lapse as a 
function of persistent pain (yes/no), high pain intensity (yes/no), and moderate-to-severe pain-
related disability (yes/no). The Kaplan Meier survival curve represents the probability of 
maintaining smoking abstinence for a given length of time while considering time in many small 
intervals (Goel, Khanna, & Kishore, 2010; Kaplan & Meier, 1958). Two survival curves can be 
compared statistically using a log-rank test to challenge the null hypothesis that the survival 
curves do not differ by group (Goel et al., 2010). If a significant log-rank result is observed (p < 
.05), then it can be concluded that the trajectory to lapse behavior differs based on group status. 
These procedures are well-established and have been previously used to examine the latency to 
smoke outcome (Roche et al., 2014).  
Finally, consistent with previous work, relapse behavior (i.e., number of cigarettes 
smoked during laboratory paradigm) as a function of pain variables and deprivation was assessed 
using ANCOVA (Langdon & Leventhal, 2014; McKee et al., 2012; Moody et al., 2017; 
Oberleitner et al., 2018; Stevenson et al., 2017; Verplaetse et al., 2017; Wilson et al., 2014). 
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Three separate ANCOVAs examined main effects of persistent pain, pain intensity, and pain-
related disability. All models included nicotine deprivation and a pain variable x nicotine 
deprivation interaction term. Significant interactions were probed using the PROCESS Macro for 
SPSS (Preacher & Hayes, 2008). For all ANCOVA models examining withdrawal scores and 
relapse behavior, the magnitude of group differences was examined using partial eta squared 
(ηp2), with values of 0.01, 0.09, and 0.25 characterizing effects as small, medium, or large 
(Richardson, 2011).  
Results  
Participant Characteristics 
 Participants included 120 current daily tobacco smokers (48% male; Mage = 36.2, SD = 
12.2) who reported smoking approximately 20 cigarettes per day (SD = 7.0) for an average of 17 
years (SD = 10.9). The mean FTND score was 5.7 (SD = 1.9), indicating a moderate level of 
tobacco dependence (Heatherton et al., 1991). The sample was predominantly white (75%), 
single (59%), and approximately 33% had completed some college. Almost half of all 
participants (44%) reported earning less than $10,000 per year.  
In terms of pain, participants reported a mean of 47.67 pain days in the past 6 months (SD 
= 64.63). Characteristic pain intensity scores ranged from 0 to 29 (M = 11.54, SD = 7.84) and 
pain-related disability scores ranged from 0 to 40 (M = 9.70, SD = 11.57). Approximately 25% 
of the sample met criteria for persistent pain (n = 31), almost 40% reported high pain intensity (n 
= 47), and approximately 26% of the sample endorsed moderate-to-severe pain-related disability 
(n = 31). Participants with persistent pain (vs. no persistent pain) were more likely to be White 
(90% vs. 70%; p = .029). A greater number of participants with high pain intensity (vs. none-to-
low pain intensity) and moderate-to-severe pain-related disability (vs. none-to-low pain-related 
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disability reported earning an income of less than $30,000 in the past year (90% vs. 70%; p = 
.014 and 93% vs. 71%, p = .035, respectively). There were no other statistically-significant 
sociodemographic differences as a function of persistent pain, pain intensity, or pain-related 
disability.  
As expected, the nicotine deprivation manipulation check revealed that deprived 
participants had significantly lower levels of expired CO (M = 5.31, SD = 2.11) than non-
deprived participants (M = 38.74, SD = 21.13; p < .001). Sociodemographic and smoking history 
data are presented in Table 1.  
Bivariate Correlations 
 All bivariate correlations are presented in Table 2. A negative correlation was observed 
between gender and number of cigarettes smoked during the laboratory paradigm (r = -.21, p = 
.019), and a positive correlation was observed between gender and MNWS scores (r = .20, p = 
.028). Specifically, females had higher MNWS scores (M = 2.27, SD = .84) than males (M = 
1.93, SD = .85; p < .05). In comparison, males smoked a greater number of cigarettes (M = 3.31, 
SD = 1.26) than females (M = 2.77, SD = 1.20; p < .05) during the laboratory paradigm. Thus, 
gender was included with FTND scores and cessation self-efficacy as covariates in subsequent 
analyses. No additional covariates were identified via bivariate analyses.  
Nicotine Withdrawal Reporting 
As expected, and consistent with findings observed in the primary study, there was a 
main effect of nicotine deprivation in all three models (Heckman et al., 2017), such that deprived 
participants reported more severe withdrawal (M = 2.27, SD = .82) than non-deprived 
participants (M = 1.92, SD = .86; p < .05). There was also a main effect of persistent pain on 
severity of withdrawal symptoms (F [1, 120] = 7.100; p = .009; ηp2 = .059), such that participants 
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with persistent pain reported experiencing more severe withdrawal (M = 2.43, SE = .14; Figure 
4), relative to those with no persistent pain (M = 1.98, SE = .09). There was no difference in 
withdrawal reporting as a function of pain intensity (F [1, 120] = 2.627; p = .108) or pain-related 
disability (F [1, 120] = .489; p = .486). We also observed no interactions between deprivation 
condition and either persistent pain (F [1, 120] = .178; p = .674), pain intensity (F [1, 120] = 
.926; p = .338), or pain-related disability (F [1, 120] = .430; p = .513). Given that interaction 
terms were not statistically-significant, only the main effects were interpreted (see Table 3). 
Unadjusted and adjusted withdrawal statistics are presented in Table 6.   
Laboratory Smoking Cessation Outcomes 
Lapse. Mean time to smoking the first cigarette (i.e., lapse) was approximately 20 
minutes (SD = 20.34) for the entire sample. Consistent with the primary study, Cox regression 
analysis showed that nicotine deprivation increased the likelihood of lapse behavior (p < .05; 
Table 4). Examination of the means revealed that participants deprived of nicotine smoked their 
first cigarette faster (M = 27.26, SD = 21.33) than those who were not deprived (M = 34.03, SD = 
18.80). As hypothesized, Cox regression analysis further revealed that pain-related disability 
predicted faster latency to lapse (HR = 2.702, p = .014; see Table 4), such that participants with 
moderate-to-severe pain-related disability were at almost three times greater risk of initiating 
smoking. These effects were evident above and beyond the variance accounted for by gender, 
cessation self-efficacy, nicotine dependence, self-control depletion condition, and nicotine 
deprivation condition. Neither persistent pain (HR = 1.652, p = .190) nor pain intensity (HR = 
1.610, p = .063) predicted lapse behavior after including covariates. We observed no significant 
interactions between nicotine deprivation condition and either persistent pain, pain intensity, or 
pain-related disability (ps > .05). Kaplan Meier survival analysis indicated that the presence of 
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moderate-to-severe pain related disability predicted a more rapid trajectory to initiating smoking 
(p = .029; Figure 5). Examination of the adjusted mean survival time revealed that participants 
with moderate-to-severe pain-related disability smoked approximately 8 minutes faster (M = 
24.58, SE = 3.57) than participants with none-to-low pain-related disability (M = 32.61, SE = 
2.12). No statistically-significant differences in lapse trajectories were observed as a function of 
persistence or intensity (ps > .05).  
Relapse. On average, participants smoked 3 cigarettes (SD = 1.26) after initiating 
smoking. There was no main effect of deprivation on number of cigarettes smoked in any model. 
Similarly, there was no effect of persistent pain (F [1, 120] = .002; p = .964), pain intensity (F [1, 
120] = 1.340; p = .249), or pain-related disability (F [1, 120] = .071; p = .791) on the relapse 
outcome. There were also no significant interactions between nicotine deprivation and either 
persistent pain (F [1, 120] = .973; p = .326), pain intensity (F [1, 120] = .416; p = .520), or pain-
related disability (F [1, 120] = .014; p = .905). Unadjusted and adjusted means for the relapse 
outcome are presented in Table 6.   
Discussion  
The current study is the first to examine clinically-relevant pain characteristics (i.e., pain 
persistence, intensity, and disability) as prospective predictors of nicotine withdrawal and 
cessation-relevant outcomes. Lapse and relapse behavior was assessed using a validated 
laboratory paradigm of smoking cessation. Results indicated that smokers with persistent pain 
(vs. no persistent pain) scored higher on a measure of nicotine withdrawal prior to completing 
the laboratory paradigm, regardless of deprivation condition assignment. Examination of the 
partial eta squared values further supported the presence of a small-to-moderate effect of 
persistent pain on nicotine withdrawal. Results also indicated that smokers with moderate-to-
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severe levels of pain-related disability initiated smoking (i.e., lapse behavior) 8 minutes faster 
than smokers with none-to-low levels of pain-related disability. Importantly, these effects were 
evident above and beyond the variance accounted for by nicotine dependence, cessation self-
efficacy, gender, nicotine deprivation condition, and self-control depletion condition. Although 
nicotine deprivation predicted both greater severity of withdrawal and increased lapse behavior 
during the laboratory paradigm, we observed no interaction between deprivation condition and 
either persistent pain or pain-related disability. We also observed no main effect of either 
deprivation condition or pain characteristics on number of cigarettes smoked (i.e., relapse 
behavior) during the experimental paradigm.   
This study advances prior work documenting that smokers with pain (vs. no pain) tend to 
experience greater difficulty (Zale et al., 2014) and more severe withdrawal when attempting to 
quit smoking (Ditre et al., 2016). Importantly, this is the first study to directly examine pain as a 
predictor of nicotine withdrawal severity. Laboratory studies have shown that some withdrawal 
symptoms emerge almost immediately after finishing a cigarette (Hendricks et al., 2006), and 
there has been interest in examining fluctuations in withdrawal reporting among continued 
smokers (Chandra et al., 2011; Perkins et al., 2009). In fact, greater withdrawal severity among 
current, non-treatment-seeking smokers has been shown to predict decreased odds of reducing 
smoking and initiating future quit attempts (Weinberger et al., 2010; Weinberger et al., 2016). 
That smokers with persistent pain reported more severe withdrawal, regardless of deprivation 
condition assignment, suggests these individuals may be less likely to successfully quit smoking, 
relative to smokers without persistent pain. Additionally, these findings also suggest that pain 
persistence may differentially predict greater nicotine withdrawal, compared to pain intensity and 
pain-related disability. Given the preliminary nature of these findings, future work is needed to 
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examine changes in withdrawal reporting among both smokers and recent quitters as a function 
of pain characteristics.  
These results also indicated that participants with moderate-to-severe pain-related 
disability (vs. none-to-low pain-related disability) were almost 3 times more likely to initiate 
smoking and smoked their first cigarette approximately 8 minutes faster during the laboratory 
paradigm of smoking cessation. In comparison, neither pain persistence nor pain intensity 
predicted lapse behavior. There was also no evidence of an interaction between nicotine 
deprivation and pain characteristics. Our finding that smokers with moderate-to-severe pain-
related disability (vs. none-to-low pain-related disability) initiated smoking faster during the 
experimental paradigm is consistent with a growing empirical literature suggesting pain is 
implicated in lapse/relapse to smoking (Aigner et al., 2017; LaRowe et al., 2017; Nakajima & 
al'Absi, 2011) and that pain-related disability may confer unique predictive utility (i.e., beyond 
pain status or intensity) in the prediction of substance-related outcomes (e.g., Zale & Ditre, 2015; 
Zale, Lange, Fields, & Ditre, 2013). For example, smokers tend to endorse higher levels of pain-
related disability than nonsmokers (Hooten et al., 2011; Patterson et al., 2012), and among 
chronic pain patients, individuals with higher pain-related disability are more likely to report 
using cigarettes as a pain-coping strategy (Patterson et al., 2012). Contrary to our hypothesis, 
there was no effect of pain persistence or pain intensity on lapse during the experimental 
paradigm. Although these findings suggest that pain-related disability may uniquely predict 
greater likelihood of lapse to smoking compared to either pain persistence or intensity, this is the 
first study to examine pain characteristics as a predictors of lapse/relapse outcomes. Additional 
work is needed to replicate these findings and further establish the predictive utility of pain-
related disability, relative to other pain characteristics, in the context of smoking cessation.   
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Strengths of the current study include its rigorous experimental design, and use of reliable 
and valid measures of pain, nicotine dependence, and smoking withdrawal. Several limitations 
also bear noting. First, participants were not recruited based on the presence of chronic pain. 
Thus, the current sample may not be representative of all smokers with chronic pain, and these 
findings should be replicated among those with varying levels of clinical pain. Nonetheless, the 
high prevalence of pain among in the current sample (e.g., approximately 40% of the sample 
endorsed high pain intensity) is consistent with other prevalence data (Bakhshaie et al., 2016), 
and supports the utility of assessing pain among all smokers, regardless of chronic pain status. 
Second, the sample was comprised of heavy smokers who were participating in an artificial quit 
attempt. Thus, the extent to which these results may generalize to lighter smokers, treatment-
seeking smokers, or smokers who are actively attempting to quit remains unclear. Third, lapse 
and relapse outcomes were assessed using a laboratory model of smoking cessation. Although 
this approach enhances internal validity (e.g., Leeman et al., 2010; Leventhal et al., 2014), 
external validity is inherently limited as these data do not reflect ‘real-world’ lapse or relapse 
processes. An important next step would be to test pain characteristics in the prediction of 
withdrawal and established cessation milestones among individuals who are actively attempting 
to quit smoking (i.e., initial abstinence, lapse, relapse; Shiffman et al., 2006). A follow-up period 
of at least two weeks has been suggested for smoking cessation research (Baker et al., 2011), as 
initial smoking lapses are most likely to occur during this timeframe (Garvey, Bliss, Hitchcock, 
Heinold, & Rosner, 1992; Hughes, Keely, & Naud, 2004). Finally, although we observed no 
significant effect of any pain characteristic on the relapse outcome (i.e., number of cigarettes 
smoked), it is common for factors that predict lapse behavior to not also predict relapse behavior 
(and vice versa) in the experimental cessation paradigm (Langdon & Leventhal, 2014; Leventhal 
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et al., 2014; Pang & Leventhal, 2013; Reitzel & Leventhal, 2014; Roche et al., 2014). For 
example, Roche and colleagues (2014) found that only 2 of 11 established risk factors 
(withdrawal and craving to relieve the discomfort of withdrawal) predicted both latency and 
number of cigarettes smoked. Collectively, these findings suggest that the laboratory paradigm 
provides distinct indices of lapse and relapse processes, and that smokers with pain-related 
disability may be more sensitive to initiating smoking.  
A growing body of evidence indicates that pain is linked to smoking behavior and the 
maintenance of tobacco dependence, and these data contribute to an emerging literature 
indicating that smokers with pain are at risk for poorer cessation outcomes. In the current study, 
persistent pain and pain-related disability independently predicted greater nicotine withdrawal 
and lapse behavior. Thus, smokers who experience persistent pain and pain-related functional 
impairment would likely benefit from tailored treatment approaches. In addition, it may be 
advisable to incorporate assessment of clinically-relevant pain characteristics among smokers 
who are preparing to quit. Cessation interventions have been successfully administered to 
smokers with chronic pain (Saragiotto et al., 2018), and integrated treatments for pain and 
smoking have been shown to increase knowledge of pain-smoking interrelations, and 
confidence/intention to quit smoking (Ditre, LaRowe, Vanable, De Vita, & Zvolensky, 2018; 
Hooten, LaRowe, Ditre, & Warner, 2018).  
In summary, this is the first study to test the role of clinically-relevant pain characteristics 
as predictors of withdrawal reporting and smoking lapse/relapse behavior. These experimental 
findings suggest that pain persistence and pain-related disability may be associated with more 
severe nicotine withdrawal and early lapse to smoking. Limited research has examined the 
effects of pain on smoking cessation, and these findings represent an initial, yet important step 
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towards better understanding the role of pain characteristics in the maintenance of tobacco 
dependence. This and future work has the potential to inform the development of tailored 
treatments, including relapse-prevention interventions (e.g, Meltzer et al., 2018), for smokers 
with co-occurring pain.  
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Table 1  
 
Sociodemographic, Smoking, and Pain Characteristics 
  
Total  
Sample 
Pain Persistence Pain Intensity Pain –Related Disability 
No Persistent Pain Persistent Pain None-to-Low High None-to-Low Moderate-to-Severe 
 n (%) n (%) n (%) n (%) n (%) n (%) n (%) 
Gender        
   Male 58 (48.3%)  44 (49.4%) 14 (45.2%) 38 (52.1%) 20 (42.6%) 47 (52.8%) 11 (35.5%) 
Race        
   White 90 (75.0%) 62 (69.7%)* 28 (90.3%)* 55 (75.3%) 35 (74.5%) 65 (73.0%) 25 (80.6%) 
   Non-White 30 (25.0%) 27 (30.3%)* 3 (9.7%)* 18 (24.7%) 12 (25.5%) 24 (27.0%) 6 (19.4%) 
Marital Status        
Single 71 (59.2%) 53 (59.6%) 18 (58.1%) 44 (60.3%) 27 (57.4%) 55 (61.8%) 16 (51.6%) 
Married 18 (15.0%) 14 (15.7%) 4 (12.9%) 11 (15.1%) 7 (14.9%) 11 (12.4%) 7 (22.6%) 
Separated/Divorced/Widowed 21 (25.8%) 22 (24.7%) 9 (29.0%) 18 (24.7%) 13 (27.7%) 23 (25.8%) 8 (25.8%) 
Education        
Did Not Graduate High School 21 (17.5%) 19 (21.3%) 2 (6.5%) 13 (17.8%) 8 (17.0%) 16 (180.0%) 5 (16.1%) 
High School Graduate 38 (31.7%) 27 (30.3%) 11 (35.5%) 24 (32.9%) 14 (29.8%) 25 (28.1%) 13 (41.9%) 
Some College or Greater 61 (50.8%) 43 (48.3%) 18 (58.0%) 36 (49.3%) 25 (53.2%) 48 (53.9%) 13 (42%) 
Income         
 <$10,000 Per Year 53 (44.2%) 40 (44.9%) 13 (41.9%) 30 (41.1%)* 23 (48.9%)* 38 (42.7%)* 15 (48.4%)* 
$10,000 - $30,000 Per Year 40 (33.3%) 27 (30.3%) 13 (41.9%) 21 (28.8%)* 19 (40.4%)* 26 (29.2%)* 14 (45.2%)* 
  >$30,000 Per Year 27 (22.5%)  22 (24.7%) 5 (16.1%) 22 (30.1%)* 5 (10.6%)* 25 (28.1%)* 2 (6.5%)* 
 M (SD) M (SD) M (SD) M (SD) M (SD) M (SD) M (SD) 
Age 36.17 (12.16) 36.36 (11.98) 35.64 (12.86) 34.68 (12.35) 38.50 (11.61) 35.51 (12.46) 38.06 (11.24) 
Cigarettes per Day 20.51 (6.99) 20.54 (7.36) 20.43 (5.90) 20.50 (6.43) 20.52 (7.85) 20.12 (6.20) 21.62 (8.90) 
Years of Smoking 16.77 (10.94) 17.37 (11.26) 15.06 (9.96) 15.37 (10.90) 18.96 (10.76) 15.68 (10.56) 19.90 (11.58) 
FTND a 5.75 (1.85) 5.71 (1.80) 5.87 (2.03) 5.61 (1.80) 5.95 (1.93) 5.66 (1.81) 6.00 (1.96) 
Cessation Self-Efficacy   .88 (.98) .88 (.98) .85 (.99) .83 (.96) .95 (1.01) .84 (.98) .97 (.97) 
Expired Carbon Monoxide  21.47 (22.31) 21.46 (23.43) 21.48 (19.05) 21.08 (24.90) 22.06 (17.80) 21.92 (23.74) 20.16 (17.85) 
Note. a FTND - Fagerström Test for Nicotine Dependence; * p < .05; ** p < .01. 
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Table 2 
 
Bivariate Correlations Between Sociodemographic, Smoking History, Primary Predictor, and Primary Outcome Variables 
Variable 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 
1 Age - .07 -.04 .08 -.14 .45** -.11 -.11 . 00 -.17 .02 .12 .15 .04 -.09 
2 Gender  - .10 .16 -.08 .19* .00 .20* .09 .00 .02 .15 .20* .07 -.21* 
3 Race   - -.30** -.13 .18* .14 .10 -.02 .14 -.20* .05 -.06 -.03 -.08 
4 Education Level    - .19* .19* -.20* .05 .10 -.06 .12 .02 .00 .15 .10 
5 Income     - -.02 -.16 -.13 .08 .11 -.08 -.14 -.15 -.07 .02 
6 Marital Status      - -.06 -.12 -.08 -.15 .00 .00 .11 .06 -.10 
7 FTND a       - .11 -.18* -.20* .00 .12 .09 .05 .04 
8 MNWS b        - -.04 .21* .20* .20* .19* -.07 .23* 
9 Cessation Self-Efficacy          - .25** -.04 .05 .04 .13 -.14 
10 Nicotine Deprivation Condition          - -.09 -.04 -.03 -.17 .07 
11 Pain Persistence           - .70** .60** -.06 .00 
12 Pain Intensity            - .80** -.08 .03 
13 Pain-Related Disability             - -.14 -.03 
14 Time to First Cigarette c                - .05 
15 Number of Cigarettes Smoked c                - 
Note. a FTND - Fagerström Test for Nicotine Dependence; b MNWS - Minnesota Nicotine Withdrawal Scale; c Outcomes (i.e., lapse 
and relapse) from Laboratory Paradigm of Smoking Cessation; * p < .05; ** p < .01. 
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Table 3 
Pain Characteristics and Nicotine Deprivation Predicting Nicotine Withdrawal Reporting  
 
 df F p ηp
2 
Persistent Pain      
FTND a  1 2.685 .104 .023 
Gender 1 5.540 .020* .046 
Cessation Self-Efficacy  1 1.328 .252 .012 
Nicotine Deprivation  1 9.917 .002** .080 
Persistent Pain  1 7.100 .009** .059 
Persistent Pain x Nicotine Deprivation  1 .178 .674 .002 
Pain Intensity     
FTND a  1 2.375 .126 .020 
Gender 1 5.119 .026* .043 
Cessation Self-Efficacy  1 1.653 .201 .014 
Nicotine Deprivation  1 9.788 .002** .079 
Pain Intensity  1 2.627 .108 .023 
Pain Intensity x Nicotine Deprivation  1 .926 .338 .008 
Pain-Related Disability      
FTND a  1 2.534 .114 .022 
Gender 1 5.100 .026* .043 
Cessation Self-Efficacy  1 1.332 .251 .012 
Nicotine Deprivation  1 8.485 .004** .069 
Pain-Related Disability  1 .489 .486 .004 
Pain-Related Disability x Nicotine Deprivation  1 .430 .513 .004 
Note. a FTND - Fagerström Test for Nicotine Dependence; * p < .05; ** p < .01. 
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Table 4 
Cox Proportional Hazards Regressions Examining Minutes to First Cigarette (i.e., Lapse) 
during the Laboratory Paradigm of Smoking Cessation  
 Adjusted Hazard Ratio 95% 
Confidence Interval 
p 
Persistent Pain   
FTND a  .965 (.841-1.106) .607 
Gender .791 (.482-1.297) .353 
Cessation Self-Efficacy  .757 (.563-1.019) .066 
Self-Control Depletion  1.712 (1.029-2.846) .038* 
Nicotine Deprivation  1.763 (.958-3.244) .068 
Persistent Pain  1.652 (.780-3.502) .190 
Persistent Pain x Nicotine Deprivation  .768 (.263-2.243) .629 
Pain Intensity   
FTND a  .963 (.839-1.106) .596 
Gender .798 (.487-1.306) .369 
Cessation Self-Efficacy  .728 (.538-.984) .039* 
Self-Control Depletion  1.759 (1.053-2.938) .031* 
Nicotine Deprivation  1.681 (1.003-2.818) .049* 
Pain Intensity  1.610 (.975-2.659) .063 
Pain Intensity x Nicotine Deprivation  .559 (.195-1.599) .278 
Pain-Related Disability    
FTND a  .952 (.832-1.090) .476 
Gender .699 (.418-1.168) .171 
Cessation Self-Efficacy  .746 (.555-1.002) .052 
Self-Control Depletion  1.815 (1.066-3.092) .028* 
Nicotine Deprivation  1.877 (1.003-3.513) .049* 
Pain-Related Disability  2.702 (1.218-5.993) .014* 
Pain-Related Disability x Nicotine Deprivation .549 (.184-1.638) .282 
Note. a FTND - Fagerström Test for Nicotine Dependence. Indicator Groups for Categorical 
Variables: Gender (Female), Self-Control Depletion (Not Depleted), Nicotine Deprivation (Not 
Deprived), Pain (No Pain); * p < .05; ** p < .01. 
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Table 5 
 
Pain Characteristics and Nicotine Deprivation Predicting Number of Cigarettes Smoked (i.e., 
Relapse) during the Laboratory Paradigm of Smoking Cessation   
 
 df F p ηp
2 
Persistent Pain      
FTND a  1 .167 .683 .001 
Gender 1 4.869 .029* .041 
Cessation Self-Efficacy  1 2.341 .129 .020 
Self-Control Depletion  1 .159 .691 .001 
Nicotine Deprivation  1 1.363 .245 .012 
Persistent Pain  1 .002 .964 .000 
Persistent Pain x Nicotine Deprivation  1 .973 .326 .009 
Pain Intensity      
FTND a  1 .101 .751 .001 
Gender 1 5.348 .023* .045 
Cessation Self-Efficacy  1 2.748 .100 .024 
Self-Control Depletion  1 .198 .657 .002 
Nicotine Deprivation  1 1.809 .181 .016 
Pain Intensity  1 1.340 .249 .012 
Pain Intensity x Nicotine Deprivation  1 .416 .520 .004 
Pain-Related Disability      
FTND a  1 .148 .701 .001 
Gender 1 4.953 .028* .042 
Cessation Self-Efficacy  1 2.386 .125 .021 
Self-Control Depletion  1 .156 .693 .001 
Nicotine Deprivation  1 1.399 .239 .012 
Pain-Related Disability  1 .071 .791 .001 
Pain-Related Disability x Nicotine Deprivation  1 .014 .905 .000 
Note. a FTND - Fagerström Test for Nicotine Dependence; * p < .05; ** p < .01. 
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Table 6  
 
Unadjusted and Adjusted Means of Primary Outcomes as a Function of Pain Characteristics 
Note. a Minnesota Nicotine Withdrawal Scale; b Outcomes (i.e., Lapse and Relapse) from Laboratory Paradigm of Smoking Cessation; 
c Adjusted for the effects of nicotine dependence (FTND scores), cessation-self efficacy, gender, and nicotine deprivation condition; d 
Adjusted for the effects of nicotine dependence (FTND scores), cessation-self efficacy, gender, nicotine deprivation condition, and 
self-control depletion condition; * p < .05; ** p < .01. 
 
 
 
 
 
 
 
Pain Persistence Pain Intensity Pain–Related Disability 
 No Persistent Pain Persistent Pain None-to-Low High None-to-Low Moderate-to-Severe 
 M (SD) M (SD) M (SD) M (SD) M (SD) M (SD) 
Unadjusted        
Nicotine Withdrawal a 1.99 (.84)* 2.42 (.81)* 2.02 (.88) 2.23 (.81) 2.06 (.83) 2.23 (.93) 
Time to First Cigarette b 31.09 (20.58) 28.95 (19.91) 31.54 (20.90) 28.97 (19.55) 32.61 (20.01)* 24.58 (20.21)* 
# of Cigarettes Smoked b 3.05 (1.29) 3.00 (1.15) 2.97 (1.34) 3.13 (1.11) 3.04 (1.28) 3.00 (1.21) 
 M (SE) M (SE) M (SE) M (SE) M (SE) M (SE) 
Adjusted        
Nicotine Withdrawal a c 1.98 (.09)* 2.43 (.14)* 2.00 (.10) 2.25 (.12) 2.07 (.09) 2.20 (.15) 
# of Cigarettes Smoked b d 3.03 (.13) 3.02 (.22) 2.92 (.15) 3.19 (.18) 2.91 (.18) 3.19 (.18) 
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Figure 1. Inclusion of Participants.  
 
 
 
 
 
 
 
 
 
 
Ineligible at experimental 
session due to other 
nicotine/tobacco use or an 
active cessation attempt  
(n = 4)  
Excluded at experimental 
session due to failure to 
meet pre-session CO 
concentration levels  
- Deprived (n = 28) 
- Non-deprived (n = 4)  
Did not complete 
smoking cessation 
paradigm  
(n = 8) 
Included in current 
analyses  
(n = 120) 
Met telephone 
screening criteria  
(n = 164)  
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Figure 2. Timeline of Study Procedures.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Recruitment Telephone Screening 
Eligible 
Participants: 
Scheduled and 
randomized to 
deprivation 
condition. 
Nicotine Deprivation 
Manipulation  
In-Person 
Experimental 
Session 
Baseline Measures 
Self-Control 
Depletion 
Manipulation 
Smoking 
Cessation 
Paradigm 
 
Responded to an 
ad for a study 
testing nicotine 
deprivation and 
smoking on self-
control 
processes.  
 
Screened for 
inclusion and 
exclusion criteria 
 
Abstain from using any 
nicotine/tobacco product for 
12 hours prior to session 
 
Complete informed 
consent, verify 
compliance with CO  
Sociodemographic, 
smoking history, pain 
characteristics, nicotine 
withdrawal symptoms 
Time to first 
cigarette, 
number of 
cigarettes 
smoked  Smoke 1 cigarette 5 minutes 
prior to session 
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Figure 3. Procedure and Primary Outcomes from the Laboratory Paradigm of Smoking Cessation.       
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Participants are given 8 
preferred brand cigarettes, an 
ashtray, and a lighter. 
Participants are informed 
that they can earn $1 for 
every 5 minutes smoking is 
delayed (up to $10) 
60-minute ad libitum 
smoking period  
After smoking is initiated or 
after 50 minutes, participants 
are instructed to “smoke as 
little or as much as you 
wish”  
Lapse Outcome = 
Latency to Smoke 
Relapse Outcome = 
Number of Cigarettes 
Smoked 
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Figure 4. Minnesota Nicotine Withdrawal Scale (MNWS) Scores as a Function of No Persistent 
Pain versus Persistent Pain. Note: Means statistically adjusted for nicotine dependence (FTND 
scores), gender, cessation self-efficacy, and nicotine deprivation condition; * p < .05. 
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Figure 5. Kaplan-Meier Survival Curves of Minutes to First Cigarette (i.e., Lapse) during the 
Laboratory Paradigm as a Function of Pain-Related Disability. 
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Appendix A  
Graded Chronic Pain Scale (GCPS)  
1. How many days in the last 6 months have you had pain?                               ______ Days  
 
2. How would you rate your pain RIGHT NOW? Use a scale from 0 to 10 where 0 is “no 
pain” and 10 is “pain as bad as could be.” 
 
No Pain                                                                                                            Pain as bad as 
                                                                                                                              could be  
  0           1           2           3           4           5           6           7           8           9           10 
 
3. In the last 3 months, how would you rate your WORST pain? Use the same scale, where 
0 is “no pain” and 10 is “pain as bad as could be.”   
 
No Pain                                                                                                            Pain as bad as 
                                                                                                                              could be  
  0           1           2           3           4           5           6           7           8           9           10 
 
4. In the last 3 months, ON AVERAGE, how would you rate your pain? Use the same 
scale, where 0 is “no pain” and 10 is “pain as bad as could be.” [That is, your usual pain 
at times you were in pain.]  
 
No Pain                                                                                                            Pain as bad as 
                                                                                                                              could be  
  0           1           2           3           4           5           6           7           8           9           10 
 
5. In the last 3 months, how many days did your pain keep your from doing your USUAL 
ACTIVITIES like work, school or housework? 
 
Days: None      1           2          3-4        5-6       7-10     11-15   16-24    25-60   61-75    76-90 
Score:  0           1           2           3           4           5           6           7           8           9           10 
 
6. In the last 3 months, how much has pain interfered with your DAILY ACTIVITIES? Use 
a 0 to 10 scale, where 0 is “no interference” and 10 is “unable to carry on any activities.”  
 
No Interference                                                                                                    Unable to carry on  
                                                                                                                                    any activities 
  0           1           2           3           4           5           6           7           8           9           10 
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7. In the last 3 months, how much has pain interfered with your RECREATIONAL, 
SOCIAL AND FAMILY ACTIVITIES? Use the same scale, where 0 is “no interference” 
and 10 is “unable to carry on any activities.” 
 
No Interference                                                                                                    Unable to carry on  
                                                                                                                                    any activities 
  0           1           2           3           4           5           6           7           8           9           10 
 
8. In the last 3 months, how much has pain interfered with your ABILITY TO WORK, 
including housework? Use the same scale, where 0 is “no interference” and 10 is “unable 
to carry on any activities.” 
 
No Interference                                                                                                    Unable to carry on  
                                                                                                                                    any activities 
  0           1           2           3           4           5           6           7           8           9           10 
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Appendix B 
 
Minnesota Nicotine Withdrawal Scale (MNWS) 
 
Please rate yourself for the period for the LAST 12 HOURS 
 None  0 
Slight 
1 
Mild 
2 
Moderate 
3 
Severe  
4 
1. Angry, irritable, frustrated           
2. Anxious, nervous           
3. Depressed mood, sad           
4. Desire or craving to smoke           
5. Difficulty concentrating           
6. Increased appetite, hungry, weight 
gain           
7. Insomnia, sleep problems, 
awakening at night           
8. Restless           
9. Impatient           
10. Constipation           
11. Dizziness           
12. Coughing           
13. Dreaming or nightmares           
14. Nausea           
15. Sore throat           
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Appendix C 
 
Fagerström Test for Nicotine Dependence (FTND) 
 
1. How soon after you wake up do you smoke your first cigarette? 
  Within 5 minutes 
  6 - 30 minutes 
  31 - 60 minutes 
  After 60 minutes 
 
2. Do you find it difficult to refrain from smoking in places where it is forbidden? For example, 
in church, at the library, at the movies etc.? 
  Yes 
  No 
 
3. Which cigarette would you hate most to give up? 
  The first one in the morning 
  All others 
 
4. How many cigarettes per day do you smoke? 
  10 or less 
  11 - 20 
  21 - 30 
  31 or more 
 
5. Do you smoke more frequently during the first hours after waking than during the rest of the 
day? 
  Yes 
  No 
 
6. Do you smoke if you are so ill that you are in bed most of the day? 
  Yes 
  No 
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